Tissue Microarray Assessment of Novel Prostate Cancer Biomarkers AMACR and EZH2 and Immunologic Response to them in African-American and Caucasian Men
Abstract
Prostate cancer is a leading cause of cancer-related death in American men. Prostate cancer like other cancers is characterized by complex molecular events influenced by diverse genetic and environmental factors. The objective of the present study was to compare the expression of AMACR and EZH2 in African-American patients and Caucasian patients with prostate cancer and understand their role. We constructed 5 tissue microarrays representing 40 African-American and 159 Caucasian prostate cancer patients and performed immunohistochemistry on these arrays using antibodies to AMACR and EZH2. Protein expression was scored on these arrays for both AMACR and EZH2. We are presently analyzing the data generated from these experiments and looking into the relative levels of the two markers in prostate cancer patients from the two racial subgroups and also for any associations with survival patterns and clinico-pathologic parameters.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 2006
- Accession Number
- ADA462682
Entities
People
- Rohit Mehra
Organizations
- University of Michigan